196 related articles for article (PubMed ID: 15886814)
21. Genetic polymorphisms in CX3CR1 predict HIV-1 disease progression in children independently of CD4+ lymphocyte count and HIV-1 RNA load.
Singh KK; Hughes MD; Chen J; Spector SA
J Infect Dis; 2005 Jun; 191(11):1971-80. PubMed ID: 15871132
[TBL] [Abstract][Full Text] [Related]
22. Common CX3CR1 alleles are associated with a reduced risk of headaches.
Combadière C; Godin O; Vidal C; Cangialosi A; Proust C; Tzourio C
Headache; 2008 Jul; 48(7):1061-6. PubMed ID: 18194290
[TBL] [Abstract][Full Text] [Related]
23. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration.
Tuo J; Smith BC; Bojanowski CM; Meleth AD; Gery I; Csaky KG; Chew EY; Chan CC
FASEB J; 2004 Aug; 18(11):1297-9. PubMed ID: 15208270
[TBL] [Abstract][Full Text] [Related]
24. Defective fractalkine-CX3CR1 signaling aggravates neuroinflammation and affects recovery from cuprizone-induced demyelination.
Mendiola AS; Church KA; Cardona SM; Vanegas D; Garcia SA; Macklin W; Lira SA; Ransohoff RM; Kokovay E; Lin CA; Cardona AE
J Neurochem; 2022 Sep; 162(5):430-443. PubMed ID: 35560167
[TBL] [Abstract][Full Text] [Related]
25. Endothelial nitric oxide synthase and fractalkine chemokine receptor polymorphisms on angiographically assessed coronary atherosclerosis.
Rios DL; Callegari-Jacques SM; Hutz MH
Clin Chim Acta; 2005 Dec; 362(1-2):138-46. PubMed ID: 16026776
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms of fractalkine receptor CX3CR1 gene in patients with symptomatic and asymptomatic carotid artery stenosis.
Kimouli M; Miyakis S; Georgakopoulos P; Neofytou E; Achimastos AD; Spandidos DA
J Atheroscler Thromb; 2009 Oct; 16(5):604-10. PubMed ID: 19755791
[TBL] [Abstract][Full Text] [Related]
27. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.
Ruth JH; Volin MV; Haines GK; Woodruff DC; Katschke KJ; Woods JM; Park CC; Morel JC; Koch AE
Arthritis Rheum; 2001 Jul; 44(7):1568-81. PubMed ID: 11465708
[TBL] [Abstract][Full Text] [Related]
28. Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis.
Fang IM; Lin CP; Yang CM; Chen MS; Yang CH
Mol Vis; 2005 Jul; 11():443-51. PubMed ID: 16030495
[TBL] [Abstract][Full Text] [Related]
29. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation.
Echigo T; Hasegawa M; Shimada Y; Takehara K; Sato S
J Allergy Clin Immunol; 2004 May; 113(5):940-8. PubMed ID: 15131578
[TBL] [Abstract][Full Text] [Related]
30. T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis.
Amanatidou V; Sourvinos G; Apostolakis S; Tsilimigaki A; Spandidos DA
Pediatr Infect Dis J; 2006 May; 25(5):410-4. PubMed ID: 16645504
[TBL] [Abstract][Full Text] [Related]
31. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.
Combadière C; Potteaux S; Gao JL; Esposito B; Casanova S; Lee EJ; Debré P; Tedgui A; Murphy PM; Mallat Z
Circulation; 2003 Feb; 107(7):1009-16. PubMed ID: 12600915
[TBL] [Abstract][Full Text] [Related]
32. T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease.
Hattori H; Ito D; Tanahashi N; Murata M; Saito I; Watanabe K; Suzuki N
Neurosci Lett; 2005 Feb; 374(2):132-5. PubMed ID: 15644279
[TBL] [Abstract][Full Text] [Related]
33. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy.
Damås JK; Boullier A; Waehre T; Smith C; Sandberg WJ; Green S; Aukrust P; Quehenberger O
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2567-72. PubMed ID: 16224053
[TBL] [Abstract][Full Text] [Related]
34. Lack of association between CX3CR1 V249I and T280M polymorphisms and risk of Parkinson's disease in a Greek population.
Kalinderi K; Bostantjopoulou S; Katsarou Z; Clarimón J; Fidani L
Genet Test Mol Biomarkers; 2012 Aug; 16(8):974-7. PubMed ID: 22747084
[TBL] [Abstract][Full Text] [Related]
35. The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis.
Stojković L; Djurić T; Stanković A; Dinčić E; Stančić O; Veljković N; Alavantić D; Zivković M
J Neuroimmunol; 2012 Apr; 245(1-2):87-92. PubMed ID: 22261545
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients.
Dimberg J; Dienus O; Löfgren S; Hugander A; Wågsäter D
Int J Colorectal Dis; 2007 Oct; 22(10):1195-200. PubMed ID: 17611763
[TBL] [Abstract][Full Text] [Related]
37. Chemokine CX3CL1 and its receptor CX3CR1 are associated with human atherosclerotic lesion volnerability.
Zhang X; Feng X; Cai W; Liu T; Liang Z; Sun Y; Yan C; Han Y
Thromb Res; 2015 Jun; 135(6):1147-53. PubMed ID: 25845619
[TBL] [Abstract][Full Text] [Related]
38. The spreading of HIV-1 infection in the human organism is caused by fractalkine trafficking of the infected lymphocytes--a review, hypothesis and implications for treatment.
Becker Y
Virus Genes; 2007 Apr; 34(2):93-109. PubMed ID: 17151939
[TBL] [Abstract][Full Text] [Related]
39. The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics.
Bursill CA; Channon KM; Greaves DR
Curr Opin Lipidol; 2004 Apr; 15(2):145-9. PubMed ID: 15017357
[TBL] [Abstract][Full Text] [Related]
40. An association study between polymorphisms of the fractalkine receptor gene, CX3CR1, and cerebral infarction in the Han Chinese population.
Li Z; Luo S; Wang F; Zhen J; Sun H; Guo C
J Neurol Sci; 2012 Sep; 320(1-2):12-5. PubMed ID: 22748631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
